1. Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry. Issue 1 (12th October 2020) Authors: Winthrop, Kevin L; Citera, Gustavo; Gold, David; Henrohn, Dan; Connell, Carol A; Shapiro, Andrea B; Shi, Harry; Onofrei, Alina M; Pappas, Dimitrios A; Schulze-Koops, Hendrik Journal: Annals of the rheumatic diseases Issue: Volume 80:Issue 1(2021) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗